Opus Genetics (IRD) Stock Price
Opus Genetics Price
Revenue has compounded at 31.3% per year over the past 19 years to 14.20 M USD. Opus Genetics's net margin stands at -349.3%, up from -9,625.3% several years earlier. Analysts set a median price target of 9.00 USD, implying 89.1% above the current price. Of 23 analysts, 22 rate the stock a buy — an overall Buy consensus. The stock trades about 188% above its 52-week low.
Opus Genetics stock price
Opus Genetics business model & stock analysis
Frequently asked questions about Opus Genetics
Analysts currently set an average price target of 9.00 USD for the Opus Genetics stock (median: 9.00 USD), implying +89.1 % versus the latest price. The consensus is based on 23 analyst ratings.
23 analysts currently rate the Opus Genetics stock: 22 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Opus Genetics to generate revenue of 11.54 M USD and earnings per share of -0.12 USD.
Converted at the current exchange rate, the Opus Genetics share trades at 4.18 EUR (4.76 USD).
The Opus Genetics share (IRD) is listed on 4 stock exchanges, including: NASDAQ (OCUP), Frankfurt (R3X1.F), München (R3X1.MU), Düsseldorf (R3X1.DU).
No history available for Opus Genetics.
The expected revenue of Opus Genetics is 11.54 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Opus Genetics is -71.56 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Opus Genetics is currently -41.39. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Opus Genetics stock.
The price-to-sales ratio (P/S) of Opus Genetics is currently 256.73. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Opus Genetics stock.
The Eulerpool Quality Score for Opus Genetics is 2/10.
The ISIN of Opus Genetics is US67577R1023. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Opus Genetics is A2QG4Z. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Opus Genetics is IRD. The ticker symbol is used to trade Opus Genetics shares on the stock exchange.
Opus Genetics paid dividends every year for the past 0 years.
Opus Genetics is assigned to the 'Health' sector.
The dividends of Opus Genetics are distributed in USD.
Opus Genetics stock
Opus Genetics Peer Group
Opus Genetics Ticker
Opus Genetics FIGI
All fundamentals and in-depth analysis of Opus Genetics
Our stock analysis for Opus Genetics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Opus Genetics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.